New hope for RA patients: drug may heal bone erosion
NCT ID NCT05955066
First seen Dec 29, 2025 · Last updated May 23, 2026 · Updated 16 times
Summary
This study tests whether baricitinib, a JAK inhibitor, can repair bone damage in people with active rheumatoid arthritis (RA). About 60 adults with RA and visible bone erosion will receive either baricitinib or a placebo for 24 weeks. Researchers will use special CT scans to see if the drug helps heal the bone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Chinese University of Hong Kong
RECRUITINGHong Kong, Hong Kong, Hong Kong
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.